Brown Brothers Harriman & Co’s Evolent Health EVH Stock Holding History

Brown Brothers Harriman & Co’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-125	Closed	-$1.06K	–	1872
2025 Q3	$1.06K	Buy	+125	New	+$1.21K	﹤0.01%	1624
2022 Q3	–	Sell	-100	Closed	-$3K	–	1524
2022 Q2	$3K	Buy	+100	New	+$2.91K	﹤0.01%	1200
2017 Q4	–	Sell	-2,000	Closed	-$36K	–	1181
2017 Q3	$36K	Hold	2,000	–	–	﹤0.01%	509
2017 Q2	$51K	Hold	2,000	–	–	﹤0.01%	479
2017 Q1	$45K	Hold	2,000	–	–	﹤0.01%	500
2016 Q4	$30K	Hold	2,000	–	–	﹤0.01%	562
2016 Q3	$49K	Buy	+2,000	New	+$46.8K	﹤0.01%	448

Other funds holding EVH

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Brothers Harriman & Co's EVH Position: Q4 2025 in Review

Brown Brothers Harriman & Co sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 125 shares — an estimated $1.06K sold.

Brown Brothers Harriman & Co first reported a position in EVH in Q3 2016 and held it in 7 quarters. The position peaked at $51K in Q2 2017. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

Brown Brothers Harriman & Co reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
Brown Brothers Harriman & Co sold 125 Evolent Health shares in Q4 2025, an estimated $1.06K.
Brown Brothers Harriman & Co first reported a position in Evolent Health in Q3 2016 and held it in 7 quarters.
Brown Brothers Harriman & Co's Evolent Health position peaked at $51K in Q2 2017.
215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2025, filed 12 Feb 2026.